• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SD filed by Hologic Inc.

    5/23/25 7:32:50 AM ET
    $HOLX
    Medical Electronics
    Health Care
    Get the next $HOLX alert in real time by email
    SD 1 a2025formsd-conflictminera.htm SD Document

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    __________________________________________________________ 
    FORM SD
     
     __________________________________________________________ 
    SPECIALIZED DISCLOSURE REPORT
     
     __________________________________________________________
    Hologic, Inc.
    (Exact name of registrant as specified in its charter)
     __________________________________________________________
    Delaware 1-36214 04-2902449
    (State or Other Jurisdiction of
    Incorporation or Organization)
     (Commission
    File Number)
     (I.R.S. Employer
    Identification No.)
    250 Campus Drive
    Marlborough, Massachusetts
     01752
    (Address of principal executive offices) (Zip Code)
    Karleen M. Oberton Telephone (508) 263-2900
    (Name and telephone number, including area code, of the person to contact in connection with this report)

     __________________________________________________________

    Check the appropriate box to indicate the rule pursuant to which this Form is being submitted, and provide the period to which the information in this Form applies:
     
    ýRule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2024.
    ☐
    Rule 13q-1 under the Securities Exchange Act (17 CFR 240.13q-1) for the fiscal year ended______________.



    SECTION 1 - Conflict Minerals Disclosure
    Items 1.01 and 1.02 Conflict Minerals Disclosure and Report, Exhibit
    A copy of Hologic, Inc.’s Conflict Minerals Report is provided as Exhibit 1.01 to this Form SD, and is publicly available at investors.hologic.com.
    The content of any website referred to in this Form SD, including any exhibit hereto, is included for general information only and is not incorporated by reference in this Form SD.
    SECTION 3 - Exhibits
    Item 3.01 Exhibits.
    Exhibit Number
      Description
    1.01
      Conflict Minerals Report of Hologic, Inc.



    Signatures
    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.
     
     HOLOGIC, INC.
    Date: May 23, 2025 By: /s/ Karleen M. Oberton
     Name: Karleen M. Oberton
     Title: Chief Financial Officer

    Get the next $HOLX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HOLX

    DatePrice TargetRatingAnalyst
    5/27/2025Hold
    Needham
    3/3/2025Buy → Hold
    Argus
    2/6/2025$80.00 → $75.00Outperform → Market Perform
    Leerink Partners
    2/3/2025Buy → Hold
    Needham
    12/13/2024Peer Perform
    Wolfe Research
    12/10/2024$90.00Buy
    Needham
    12/10/2024$85.00Hold
    Jefferies
    10/1/2024$95.00 → $85.00Buy → Neutral
    Citigroup
    More analyst ratings

    $HOLX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Needham reiterated coverage on Hologic

      Needham reiterated coverage of Hologic with a rating of Hold

      5/27/25 1:53:30 PM ET
      $HOLX
      Medical Electronics
      Health Care
    • Hologic downgraded by Argus

      Argus downgraded Hologic from Buy to Hold

      3/3/25 8:06:16 AM ET
      $HOLX
      Medical Electronics
      Health Care
    • Hologic downgraded by Leerink Partners with a new price target

      Leerink Partners downgraded Hologic from Outperform to Market Perform and set a new price target of $75.00 from $80.00 previously

      2/6/25 7:06:39 AM ET
      $HOLX
      Medical Electronics
      Health Care

    $HOLX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Div. President, GYN Surgical Schnittker Brandon covered exercise/tax liability with 69 shares, decreasing direct ownership by 1% to 6,094 units (SEC Form 4)

      4 - HOLOGIC INC (0000859737) (Issuer)

      6/3/25 4:19:30 PM ET
      $HOLX
      Medical Electronics
      Health Care
    • Director Madaus Martin D bought $300,760 worth of shares (5,445 units at $55.24) (SEC Form 4)

      4 - HOLOGIC INC (0000859737) (Issuer)

      5/9/25 4:39:33 PM ET
      $HOLX
      Medical Electronics
      Health Care
    • New insider Liddy Anne M. claimed ownership of 11,426 shares (SEC Form 3)

      3 - HOLOGIC INC (0000859737) (Issuer)

      5/2/25 4:52:34 PM ET
      $HOLX
      Medical Electronics
      Health Care

    $HOLX
    Leadership Updates

    Live Leadership Updates

    See more
    • Biote Announces CEO Retirement and Succession Plan

      Terry Weber Retiring as CEO and Director and Transitioning to Strategic Advisor to Company's Board of Directors Health Care Veteran Bret Christensen to Succeed Terry Weber as CEO and Director biote Corp. (NASDAQ:BTMD) ("Biote" or the "Company"), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced that Terry Weber is retiring as Chief Executive Officer and stepping down from the Company's Board of Directors, effective as of February 1, 2025. She will be transitioning to Strategic Advisor to the Company's Board of Directors. Concurrently, Mr. Bret Christensen has been named Chief Executi

      1/30/25 4:10:00 PM ET
      $BTMD
      $HOLX
      $MYGN
      $PODD
      Medicinal Chemicals and Botanical Products
      Health Care
      Medical Electronics
      Biotechnology: In Vitro & In Vivo Diagnostic Substances
    • CellMax Life Announces Expansion of Company Board With Leading Industry Experts

      Renowned industry experts join to aid in preparation around premarket approval for FirstSight SUNNYVALE, Calif., April 6, 2023 /PRNewswire-PRWeb/ -- CellMax Life, a molecular diagnostics company with a proprietary colorectal cancer screening blood test, today announced the appointment of Stanley N. Lapidus (Stan) as an advisory board member and Ronnie (Ron) Andrews as an independent board member. The announcement comes only one month after CellMax Life expanded its GI advisory board with luminaries in the GI arena. "Both Stan and Ron are pioneers in the diagnostics industry, with unique perspectives and proven track records of success," said Atul Sharan, CEO of CellMax Life. Stan is one of t

      4/6/23 9:00:00 AM ET
      $EXAS
      $HOLX
      Medical Specialities
      Health Care
      Medical Electronics
    • IMPULSE DYNAMICS APPOINTS FIVE NEW BOARD MEMBERS

      MARLTON, N.J., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Impulse Dynamics N.V., a company dedicated to improving the lives of people with heart failure (HF), today announced the election of five new members to its Board of Directors at the most recent meeting of its shareholders.  "We are extremely pleased to have Jim Tobin, Joe Capper, Glenn Muir, John Bakewell, and Dan Scavila all joining our board of directors," said Prof. Shlomo Ben-Haim, Chairman of the Board and Founder of Impulse Dynamics.  "This is an illustrious group to be adding to the board, and I am extremely pleased to be welcoming and working with all of them as we rapidly advance our goals for the company, for CCM therapy, and mo

      11/11/21 7:26:31 PM ET
      $BEAT
      $GMED
      $GTHX
      $HOLX
      Medical/Dental Instruments
      Health Care
      Biotechnology: Pharmaceutical Preparations
      Medical Electronics